• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL1900014 Mirikizumab注射液 mirikizumab Injection Biological Products Import Drug Application 2019-02-18 Eli Lilly & Company In Review 2019-02-16 view
JXSL1900015 Mirikizumab注射液 mirikizumab Injection Biological Products Import Drug Application 2019-02-18 Eli Lilly & Company In Review 2019-02-16 view
JXSL1900094 Mirikizumab注射液 mirikizumab Injection Biological Products Import Drug Application 2019-09-23 Eli Lilly & Company In Review 2019-09-21 view
JXSL1900093 Mirikizumab注射液 mirikizumab Injection Biological Products Import Drug Application 2019-09-23 Eli Lilly & Company In Review 2019-09-21 view
JXSL1900092 Mirikizumab注射液 mirikizumab Injection Biological Products Import Drug Application 2019-09-23 Eli Lilly & Company In Review 2019-09-21 view
JXSL1900112 Mirikizumab注射液 mirikizumab Injection Biological Products Import Drug Application 2019-11-01 Eli Lilly & Company In Review 2019-10-31 view
JXSL2000073 Mirikizumab注射液 mirikizumab Injection Biological Products Import Drug Application 2020-06-10 Eli Lilly & Company In Review 2020-06-09 view
JXSL2000075 Mirikizumab注射液 mirikizumab Injection Biological Products Import Drug Application 2020-06-10 Eli Lilly & Company In Review 2020-06-09 view
JXSL2000074 Mirikizumab注射液 mirikizumab Injection Biological Products Import Drug Application 2020-06-10 Eli Lilly & Company In Review 2020-06-09 view
JYSB2000239 Mirikizumab注射液 mirikizumab Injection Biological Products Supplementary Application 2020-06-19 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2020-06-18 view
JYSB2000238 Mirikizumab注射液 mirikizumab Injection Biological Products Supplementary Application 2020-06-19 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2020-06-18 view
JYSB2000240 Mirikizumab注射液 mirikizumab Injection Biological Products Supplementary Application 2020-06-19 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2020-06-18 view
JXSB2000015 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2020-09-17 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2020-09-16 view
JXSB2000014 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2020-09-17 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2020-09-16 view
JXSB2100016 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-02-27 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-02-26 view
JXSB2100024 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-03-19 view
JXSB2100023 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-03-19 view
JXSB2100025 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-03-19 view
JXSB2101032 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-07-13 Eli Lilly & Company view
JXSB2101033 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-07-13 Eli Lilly & Company view